Diabetes and COVID-19

Diabetes and COVID-19

Open Access
Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters
Barrak Alahmad, Abdullah A. Al-Shammari, Abdullah Bennakhi, Fahd Al-Mulla, Hamad Ali

Diabetes Care Oct 2020, dc201941; DOI: 10.2337/dc20-1941
Open Access
Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study
Matthieu Wargny, Pierre Gourdy, Lisa Ludwig, Dominique Seret-Bégué, Olivier Bourron, Patrice Darmon, Coralie Amadou, Matthieu Pichelin, Louis Potier, Charles Thivolet, Jean-François Gautier, Samy Hadjadj, Bertrand Cariou, for the CORONADO investigators

Diabetes Care Aug 2020, dc201217; DOI: 10.2337/dc20-1217
Open Access
Did the COVID-19 Lockdown Affect the Incidence of Pediatric Type 1 Diabetes in Germany?
Sascha René Tittel, Joachim Rosenbauer, Clemens Kamrath, Julian Ziegler, Felix Reschke, Johanna Hammersen, Kirsten Mönkemöller, Angeliki Pappa, Thomas Kapellen, Reinhard Walter Holl

Diabetes Care Aug 2020, dc201633; DOI: 10.2337/dc20-1633
Open Access
New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K.
Rebecca Unsworth, Susan Wallace, Nick S. Oliver, Shunmay Yeung, Archana Kshirsagar, Harshini Naidu, Ruth Min Wai Kwong, Priya Kumar, Karen M. Logan

Diabetes Care Aug 2020, dc201551; DOI: 10.2337/dc20-1551
Open Access
Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children?
Ivana Rabbone, Riccardo Schiaffini, Valentino Cherubini, Claudio Maffeis, Andrea Scaramuzza, the Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes*

Diabetes Care Aug 2020, dc201321; DOI: 10.2337/dc20-1321
Open Access
COVID-19 and Children With Diabetes—Updates, Unknowns, and Next Steps: First, Do No Extrapolation
Linda A. DiMeglio, Anastasia Albanese-O’Neill, Cynthia E. Muñoz, David M. Maahs

Diabetes Care Sep 2020, dci200044; DOI: 10.2337/dci20-0044
Open Access
The Impact of COVID-19 on CGM Use in the Hospital
Nicole Ehrhardt, Irl B. Hirsch

Diabetes Care Sep 2020, dci200046; DOI: 10.2337/dci20-0046
Open Access
Reduced COVID-19 Mortality With Sitagliptin Treatment? Weighing the Dissemination of Potentially Lifesaving Findings Against the Assurance of High Scientific Standards
Michael A. Nauck, Juris J. Meier

Diabetes Care Oct 2020, dci200062; DOI: 10.2337/dci20-0062
Open Access
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
Sebastiano Bruno Solerte, Francesca D’Addio, Roberto Trevisan, Elisabetta Lovati, Antonio Rossi, Ida Pastore, Marco Dell’Acqua, Elio Ippolito, Cristiana Scaranna, Rosalia Bellante, Silvia Galliani, Alessandro Roberto Dodesini, Giuseppe Lepore, Francesca Geni, Roberta Maria Fiorina, Emanuele Catena, Angelo Corsico, Riccardo Colombo, Marco Mirani, Carlo De Riva, Salvatore Endrio Oleandri, Reza Abdi, Joseph V. Bonventre, Stefano Rusconi, Franco Folli, Antonio Di Sabatino, Gianvincenzo Zuccotti, Massimo Galli, Paolo Fiorina

Diabetes Care Sep 2020, dc201521; DOI: 10.2337/dc20-1521
Open Access
Diabetes and COVID-19: Moving From News to Knowledge and a Glucose Hypothesis
Matthew C. Riddle

Diabetes Care Oct 2020, 43 (10) 2336-2338; DOI: 10.2337/dci20-0045

Main menu

User menu

Search

Diabetes and COVID-19

Pages

Navigate

More Information

Other ADA Resources